Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease-Reference-Cited by-同舟云学术

Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease

Published:2018-06-13 Issue:6 Volume:13 Page:e0198144
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Ramchand Jay,Patel Sheila K.,Srivastava Piyush M.,Farouque Omar,Burrell Louise M.^ORCID

Funder

National Health and Medical Research Council

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association;EJ Benjamin;Circulation,2017

2. The role of ACE2 in cardiovascular physiology;GY Oudit;Trends Cardiovasc Med,2003

3. Vasoprotective and atheroprotective effects of angiotensin (1–7) in apolipoprotein E-deficient mice;S Tesanovic;Arterioscler Thromb Vasc Biol,2010

4. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9;M Donoghue;Circ Res,2000

5. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2);DW Lambert;J Biol Chem,2005

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CHA2DS2-VASc predicts readmission, outcomes and resource utilization in patients undergoing coronary artery bypass grafting: A 7-year National Readmission Database study;International Journal of Cardiology;2024-12

2. Guideline-directed medical therapy prescribing patterns and in-hospital outcomes among heart failure patients during COVID-19;American Heart Journal Plus: Cardiology Research and Practice;2024-09

3. Efficiency and Safety of Intracoronary Epinephrine Administration in Patients With ST-Elevation Myocardial Infarction With Refractory Coronary No-Reflow;The American Journal of Cardiology;2024-09

4. Intracoronary Administration of Epinephrine in the Refractory No-Reflow Phenomenon in Patients With Acute Myocardial Infarction;Kardiologiia;2024-06-30

5. Plasma Soluble Angiotensin-Converting Enzyme 2 and Risk of Recurrent Stroke: A Nested Case-Control Analysis;Cerebrovascular Diseases;2024-03-12